Home — MRC Weatherall Institute of Molecular Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Academy of Medical Sciences elects Professor Tao Dong as new Fellow

Congratulations to Tao Dong, who has been elected a Fellow of the Academy of Medical Sciences in recognition of her outstanding contributions to advancing medical science through discovery research, translational studies, and the application of scientific knowledge for patient and public benefit.

Read more

Banner image featuring the words a leader in translating research from bench to clinic, next to an image of a scientist pipetting a pink liquid.

Translating Our Research

Leading research with the aim of improving human health. World-leading research from scientists at the MRC WIMM has been developed into commercial ventures to translate our discoveries into clinics and benefit patients.

Read more

Researcher hanlding patient samples in a lab.

© Adobe Stock

Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies

Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb (BMS), and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma.

Read more

Research at the MRC WIMM spans 5 core areas.

© Canva, Science Photo Library

MRC WIMM Research Areas

Research at the MRC WIMM spans 5 core areas.

Read more

Fluorescent imaging of a zebrafish embryo highlights cell populations during early development. The image reflects the type of dynamic biological system researchers used to test RegVelo, a new AI framework for predicting how cells acquire their identities and identifying the genetic regulators that guide them.

© Stowers Institute for Medical Research

New AI model predicts how cells choose their fate

Researchers from the University of Oxford, the Stowers Institute for Medical Research, Helmholtz Munich, and the Technical University of Munich have developed a new artificial intelligence framework that helps uncover how cells make developmental decisions.

Read more

The MRC WIMM's core mission is to improve human health through the pursuit of fundamental research, the development of new technology, and the translation of discoveries to the clinic.

Discover. Translate. Advance.

The MRC WIMM's core mission is to improve human health through the pursuit of fundamental research, the development of new technology, and the translation of discoveries to the clinic.

Read more

MRC Translational Immune Discovery Unit

Pioneering the future in the study of human immunity to uncover the molecular pathways driving immune-mediated diseases.

Find out more

MRC Molecular Haematology Unit

Understanding how mature blood cells are normally made from stem cells and how this is perturbed in common blood disorders.

Find out more

Centre for Computational Biology

Using computational biology to help understand complex biological systems and combat a range of human diseases.

Find out more

Latest publications

TiO2 Alternative Coatings for Ferric Pyrophosphate Premixes: Stability and Bioaccessibility Relative to Ferrous Fumarate

Teichman DL. et al, (2026), Innovative Food Science and Emerging Technologies, 111

Initial leukemic epigenomic state determines hypomethylating agent response.

Gopal A. et al, (2026), Nat Commun

PD-1 signaling and PD-1 blockade-mediated tumor control are established at microvillar T cell contacts.

Jenkins E. et al, (2026), Sci Immunol, 11

Mezigdomide reverses T-cell exhaustion through degradation of IKZF1/IKZF3 and reinvigoration of cytokine production pathways.

Chiu H. et al, (2026), Blood

Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

Chen LY. et al, (2026), Blood

More Publications

Upcoming Seminars

Infections, vaccines, and brain health

Friday, 29 May 2026, 9.15am to 10.15am

Speaker(s): Prof Maxime Taquet

Series: MRC TIDU Friday Morning Lab Meetings

Scalable Tools to Map T Cell Recognition

Monday, 01 June 2026, 3pm to 4pm

Speaker(s): Dr Stephanie Gaglione (Gladstone Institute)

Series: Unravelling T Cell Recognition: Insights from Immunology and AI

Methylation states underlying clonal fitness at single cell resolution

Tuesday, 02 June 2026, 1pm to 2pm

Speaker(s): Alba Rodriguez Meira, PhD

Series: Molecular Haematology Unit, WIMM

Extrachromosomal DNA (ecDNA): Cancer's Dynamic Circular Genome

Wednesday, 03 June 2026, 12pm to 1pm

Speaker(s): Professor Paul Salomon Mischel (Stanford University)

Series: Molecular Haematology Unit, WIMM

More Seminars

MRC WIMM Interactive Timeline

Accessible Version of Timeline